Tags: Drug.

Elvucitabine is an experimental nucleoside reverse transcriptase inhibitor (NRTI) developed by Achillion Pharmaceuticals Inc. for the treatment of HIV.Currently it is in Phase II clinical trials.

Elvucitabine.png
ATC prefix
none
CAS number
181785-84-2
FDA UNII code
M09BUF90C0
IUPAC name
4-amino-5-fluoro-1-[(2S5R)-5-(hydroxymethyl)-25-dihydrofuran-2-yl]pyrimidin-2-one
PubChem
469717

Loading...

This page contains content from the copyrighted Wikipedia article "Elvucitabine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.